Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccines.
OBJECTIVES:: Protection against HIV type 1 (HIV-1) infection/AIDS will likely require concerted actions of protective CD8 killer T cells and protective antibodies. The challenges in inducing such effectors by active immunization are such that the T-cell and antibody vaccine components require separa...
Main Authors: | Clutton, G, Carpov, A, Parks, C, Dean, H, Montefiori, D, Hanke, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott Williams and Wilkins
2014
|
Similar Items
-
Parallel induction of CH505 B cell ontogeny-guided neutralizing antibodies and tHIVconsvX conserved mosaic-specific T cells against HIV-1
by: Wee, E, et al.
Published: (2019) -
Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
by: Edmund G. Wee, et al.
Published: (2022-06-01) -
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
by: Michael Vaine, et al.
Published: (2010-11-01) -
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
by: Kevin O. Saunders, et al.
Published: (2017-12-01) -
Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant
by: Lázaro Moreira Marques Neto, et al.
Published: (2018-11-01)